Inicio>>Signaling Pathways>> Neuroscience>> nAChR>>Anabasine ((S)-Anabasine)

Anabasine ((S)-Anabasine)

Catalog No.GC30866

La anabasina ((S)-anabasina) ((S)-anabasina ((S)-anabasina)) es un alcaloide que se encuentra como componente menor en el tabaco (Nicotiana).

Products are for research use only. Not for human use. We do not sell to patients.

Anabasine ((S)-Anabasine) Chemical Structure

Cas No.: 494-52-0

Tamaño Precio Disponibilidad Cantidad
10mM (in 1mL DMSO)
61,00 $
Disponible
10mg
56,00 $
Disponible
25mg
82,00 $
Disponible
50mg
147,00 $
Disponible
100mg
258,00 $
Disponible

Tel:(909) 407-4943 Email: sales@glpbio.com

Reseñas de cliente

Based on customer reviews.

  • GlpBio Citations

    GlpBio Citations
  • Bioactive Compounds Premium Provider

    Bioactive Compounds Premium Provider

Sample solution is provided at 25 µL, 10mM.

Description Protocol Chemical Properties Product Documents Related Products

Anabasine is a nicotinic receptor agonist.

Anabasine significantly reverses the impairment at the 0.2 mg/kg (p<0.05) and 2 mg/kg doses (p<0.025). Anabasine does not have any significant effects on response latency when administered alone. The 0.06 mg/kg Anabasine dose, in fact, significantly (p<0.05) exacerbates the dizocilpine-induced impairment. None of these Anabasine doses affects choice accuracy on their own. Individual dose comparisons show that the 0.06 mg/kg Anabasine dose plus dizocilpine (6.7±2.6) causes a significant (p<0.05) increase in non-response trials compare with dizocilpine alone (2.1±0.8)[1].

[1]. Levin ED, et al. Effects of tobacco smoke constituents, anabasine and anatabine, on memory and attention in female rats. J Psychopharmacol. 2014 Oct;28(10):915-22.

Reseñas

Review for Anabasine ((S)-Anabasine)

Average Rating: 5 ★★★★★ (Based on Reviews and 36 reference(s) in Google Scholar.)

5 Star
100%
4 Star
0%
3 Star
0%
2 Star
0%
1 Star
0%
Review for Anabasine ((S)-Anabasine)

GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.

Required fields are marked with *

You may receive emails regarding this submission. Any emails will include the ability to opt-out of future communications.